The predictive capacity of in vitro preclinical models to evaluate drugs for the treatment of retinoblastoma.

Sinenko, Irina L; Turnell-Ritson, Roland C; Munier, Francis L; Dyson, Paul J

Sinenko, Irina L; Turnell-Ritson, Roland C; Munier, Francis L; Dyson, Paul J.

Afiliación

Sinenko IL; Institute of Chemical Sciences and Engineering, École Polytechnique Fédérale de Lausanne (EPFL), CH-1015, Lausanne, Switzerland; Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, CH-1004, Lausanne, Switzerland.
Turnell-Ritson RC; Institute of Chemical Sciences and Engineering, École Polytechnique Fédérale de Lausanne (EPFL), CH-1015, Lausanne, Switzerland.
Munier FL; Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, CH-1004, Lausanne, Switzerland. Electronic address: francis.munier@fa2.ch.
Dyson PJ; Institute of Chemical Sciences and Engineering, École Polytechnique Fédérale de Lausanne (EPFL), CH-1015, Lausanne, Switzerland.

Exp Eye Res ; 230: 109447, 2023 05.

Article en En | MEDLINE | ID: mdl-36940901

Asunto(s)

Neoplasias de la Retina; Retinoblastoma; Humanos; Niño; Retinoblastoma/tratamiento farmacológico; Evaluación Preclínica de Medicamentos; Neoplasias de la Retina/tratamiento farmacológico

Palabras clave

Drug discovery; Retinoblastoma; Three-dimensional models; Tumour organoids

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Retinoblastoma / Neoplasias de la Retina Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Exp Eye Res Año: 2023 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google